Matt Miksic

Stock Analyst at Barclays

(3.84)
# 622
Out of 4,884 analysts
282
Total ratings
61.33%
Success rate
4.37%
Average return

Stocks Rated by Matt Miksic

Bausch + Lomb
Jun 9, 2025
Maintains: Equal-Weight
Price Target: $19$16
Current: $13.88
Upside: +15.27%
Becton, Dickinson and Company
Jun 3, 2025
Maintains: Overweight
Price Target: $261$241
Current: $176.16
Upside: +36.81%
LivaNova
May 8, 2025
Maintains: Equal-Weight
Price Target: $56$55
Current: $46.13
Upside: +19.23%
Orchestra BioMed Holdings
May 5, 2025
Maintains: Overweight
Price Target: $16$12
Current: $2.89
Upside: +315.22%
DexCom
May 5, 2025
Maintains: Equal-Weight
Price Target: $90$93
Current: $82.93
Upside: +12.14%
Insulet
Apr 30, 2025
Maintains: Equal-Weight
Price Target: $234$266
Current: $301.05
Upside: -11.64%
InMode
Apr 30, 2025
Maintains: Overweight
Price Target: $29$24
Current: $15.16
Upside: +58.31%
Boston Scientific
Apr 25, 2025
Maintains: Overweight
Price Target: $118$125
Current: $104.32
Upside: +19.82%
Intuitive Surgical
Apr 24, 2025
Maintains: Overweight
Price Target: $684$635
Current: $544.47
Upside: +16.63%
Johnson & Johnson
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $166$165
Current: $156.01
Upside: +5.76%
Maintains: Overweight
Price Target: $158$159
Current: $134.44
Upside: +18.27%
Maintains: Overweight
Price Target: $39$41
Current: $31.01
Upside: +32.22%
Maintains: Overweight
Price Target: $60$53
Current: $16.78
Upside: +215.85%
Maintains: Overweight
Price Target: $100$103
Current: $59.17
Upside: +74.07%
Maintains: Overweight
Price Target: $88$90
Current: $76.79
Upside: +17.20%
Maintains: Underweight
Price Target: $118$112
Current: $93.67
Upside: +19.57%
Maintains: Overweight
Price Target: $418$443
Current: $395.28
Upside: +12.07%
Maintains: Overweight
Price Target: $20$21
Current: $10.99
Upside: +91.08%
Initiates: Overweight
Price Target: $22
Current: $3.80
Upside: +478.95%
Maintains: Overweight
Price Target: $105$109
Current: $88.39
Upside: +23.32%
Maintains: Underweight
Price Target: $13$16
Current: $10.25
Upside: +56.10%
Assumes: Outperform
Price Target: $96
Current: $87.78
Upside: +9.36%
Assumes: Outperform
Price Target: $100
Current: $74.67
Upside: +33.92%
Maintains: Outperform
Price Target: $722$418
Current: $196.82
Upside: +112.38%
Maintains: Outperform
Price Target: $31$28
Current: $11.75
Upside: +138.40%
Maintains: Outperform
Price Target: $68$67
Current: $16.67
Upside: +301.92%
Initiates: Outperform
Price Target: $480
Current: $7.61
Upside: +6,207.49%
Maintains: Outperform
Price Target: $84$87
Current: $13.49
Upside: +544.92%
Maintains: Outperform
Price Target: $24$25
Current: $4.25
Upside: +488.24%
Initiates: Sell
Price Target: $9
Current: $6.34
Upside: +41.96%